| scholarly article | Q13442814 |
| P50 | author | Benjamin Frey | Q38326649 |
| Gerhard Thiel | Q50674837 | ||
| P2093 | author name string | Claudia Fournier | |
| Udo S Gaipl | |||
| Gerhart Klein | |||
| Daniela Kraft | |||
| Aljona Cucu | |||
| Paul Friedrich Rühle | |||
| Kateryna Shreder | |||
| P2860 | cites work | A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity | Q24615651 |
| The molecular mechanism of osteoclastogenesis in rheumatoid arthritis | Q24806322 | ||
| Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines | Q28083665 | ||
| The pathogenesis of rheumatoid arthritis | Q29614957 | ||
| Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort | Q30839061 | ||
| Osteophytes, juxta-articular radiolucencies and cancellous bone changes in the proximal tibia of patients with knee osteoarthritis | Q33253743 | ||
| Adipokines: Biomarkers for osteoarthritis? | Q33891957 | ||
| Long-term efficacy of radon spa therapy in rheumatoid arthritis--a randomized, sham-controlled study and follow-up | Q33914779 | ||
| Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. | Q33950766 | ||
| Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice. | Q33966587 | ||
| The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis | Q34169053 | ||
| Pharmacologic pain treatment of musculoskeletal disorders: current perspectives and future prospects | Q34209485 | ||
| Radon therapy for the treatment of rheumatic diseases--review and meta-analysis of controlled clinical trials | Q34283417 | ||
| Expression of activin A in inflammatory arthropathies. | Q34307744 | ||
| Serum adipokine levels in rheumatoid arthritis patients and their contributions to the resistance to treatment | Q34381384 | ||
| IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance | Q34512092 | ||
| The weight of leptin in immunity | Q35762436 | ||
| Mechanistic insight into osteoclast differentiation in osteoimmunology | Q36073894 | ||
| Mechanisms of Disease: the link between RANKL and arthritic bone disease | Q36577375 | ||
| Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations | Q36800978 | ||
| Biological markers in osteoarthritis | Q36835538 | ||
| Role of adipokines signaling in the modulation of T cells function. | Q37236046 | ||
| Osteoimmunology and the effects of the immune system on bone | Q37626412 | ||
| Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. | Q37823835 | ||
| What's new in our understanding of the role of adipokines in rheumatic diseases? | Q37909903 | ||
| Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review | Q38041853 | ||
| New horizons in osteoarthritis | Q38097332 | ||
| Emerging cell and cytokine targets in rheumatoid arthritis | Q38161794 | ||
| Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. | Q38649096 | ||
| Adipokines in bone disease | Q38808869 | ||
| The joint synovium: A critical determinant of articular cartilage fate in inflammatory joint diseases | Q38841413 | ||
| Long-term benefits of radon spa therapy in rheumatic diseases: results of the randomised, multi-centre IMuRa trial | Q39223667 | ||
| Efficacy of diclofenac in lateral epicondylitis of the elbow also treated with immobilization. The University of Montreal Orthopaedic Research Group. | Q39446041 | ||
| Randomised trial of oral morphine for chronic non-cancer pain | Q39468030 | ||
| Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | Q39936079 | ||
| Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study | Q41257640 | ||
| Synovial tissue inflammation in early and late osteoarthritis | Q43048512 | ||
| Physical disability among Canadians reporting musculoskeletal diseases | Q44680835 | ||
| Radon balneotherapy and physical activity for osteoporosis prevention: a randomized, placebo-controlled intervention study. | Q48063993 | ||
| Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. | Q50659459 | ||
| Modulation of the peripheral immune system after low-dose radon spa therapy: Detailed longitudinal immune monitoring of patients within the RAD-ON01 study. | Q50860416 | ||
| Association between adiponectin and cartilage degradation in human osteoarthritis. | Q51165838 | ||
| Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. | Q51429519 | ||
| Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis | Q57779892 | ||
| Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: A randomized controlled trial | Q60473186 | ||
| Radon solubility in rat tissues | Q74430424 | ||
| Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial | Q74760892 | ||
| Long-term benefit of radon spa therapy in the rehabilitation of rheumatoid arthritis: a randomised, double-blinded trial | Q79488731 | ||
| Tumor necrosis factor inhibitors for rheumatoid arthritis | Q80129386 | ||
| Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis | Q80846616 | ||
| Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis | Q81739887 | ||
| [Adiponectin as target in rheumatoid arthritis] | Q87411773 | ||
| The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis | Q89136303 | ||
| P304 | page(s) | 882 | |
| P577 | publication date | 2017-07-25 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Decrease of Markers Related to Bone Erosion in Serum of Patients with Musculoskeletal Disorders after Serial Low-Dose Radon Spa Therapy | |
| P478 | volume | 8 |
| Q92004875 | Balneotherapy and human immune function in the era of COVID-19 |
| Q60919302 | Changes of 8-OHdG and TrxR in the Residents Who Bathe in Radon Hot Springs |
| Q89768272 | Effects of Radon From Hot Springs on Lymphocyte Subsets in Peripheral Blood |
| Q87944374 | Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
| Q58749665 | Impact of X-ray Exposure on the Proliferation and Differentiation of Human Pre-Adipocytes |
| Q47720058 | Long-term efficacy of spa therapy in patients with rheumatoid arthritis. |
| Q58555676 | Low-Dose Radiotherapy Has No Harmful Effects on Key Cells of Healthy Non-Inflamed Joints |
Search more.